Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
Emerging Infectious Diseases - United States
doi 10.3201/eid2509.190105
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2019
Authors
Publisher
Centers for Disease Control and Prevention (CDC)